Filing Details

Accession Number:
0001209191-23-025911
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-27 19:02:45
Reporting Period:
2023-04-25
Accepted Time:
2023-04-27 19:02:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1679363 Morphic Holding Inc. MORF Pharmaceutical Preparations (2834) 473878772
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780273 Bruce Rogers C/O Morphic Holding, Inc.
35 Gatehouse Drive, A2
Waltham MA 02451
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-25 30,000 $4.32 147,055 No 4 M Direct
Common Stock Disposition 2023-04-25 30,000 $53.40 117,055 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy Common Stock) Disposition 2023-04-25 30,000 $0.00 30,000 $4.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
98,114 2028-12-14 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated November 16, 2021.
  2. The option is fully vested.